Tulobuterol hydrochloride
Tulobuterol hydrochloride Basic information
- Product Name:
- Tulobuterol hydrochloride
- Synonyms:
-
- Ventaire
- Tulobuterol hydrochloride API
- Tulobuterol solution
- Tulobuterol Hydrochloride Solution, 100ppm
- TULOBUTEROL HCl 99%
- TULOBUTEROL HG
- Atenos
- Benzenemethanol, 2-chloro-a-[[(1,1-dimethylethyl)amino]methyl]-, hydrochloride (9CI)
- CAS:
- 56776-01-3
- MF:
- C12H19Cl2NO
- MW:
- 264.19
- EINECS:
- 634-677-4
- Product Categories:
-
- API
- Active Pharmaceutical Ingredients
- Mol File:
- 56776-01-3.mol
Tulobuterol hydrochloride Chemical Properties
- Melting point:
- 159-163℃
- storage temp.
- 2-8°C
- solubility
- DMSO (Slightly), Methanol (Slightly)
- form
- Solid
- color
- White
- Water Solubility
- Soluble in methanol or water.
- Sensitive
- Hygroscopic
- Merck
- 14,9811
- InChIKey
- RSLNRVYIRDVHLY-UHFFFAOYSA-N
- CAS DataBase Reference
- 56776-01-3(CAS DataBase Reference)
Tulobuterol hydrochloride Usage And Synthesis
Uses
Hydrochloride salt of Tulobuterol a sympathomimetic drug used as a transdermal patch, increases normal diaphragm muscle strength. A β-adrenergic receptor agonist, related structurally to Terbutaline (T109750).
Uses
Tulobuterol hydrochloride (C-78) is a long-acting β2-adrenoceptor agonist, which reduces the frequency of exacerbations of chronic obstructive pulmonary disease and bronchial asthma. Tulobuterol hydrochloride is also a sympathomimetic agent used as a transdermal patch, increases normal diaphragm muscle strength. Tulobuterol hydrochloride inhibit rhinovirus replication and modulate airway inflammation.
Definition
ChEBI: Tulobuterol hydrochloride is an organic molecular entity.
General Description
Standard for Supelco MIP SPE cartridges. For more information request Supelco Literature T407075, T706019, T706030, T706020
in vivo
In vivo effect of Tulobuterol is examined the on the contractility of diaphragm muscles prepared from mice (BALBs/c mice; 21.7 ± 0.2 g) treated with Endotoxin. Contractile parameters of force-frequency curves and twitch kinetics using untreated or treated diaphragm muscles at 0 (E0) and 4 (E4) hours after E. coli endotoxin (20 mg/kg) administration are measured. E0 and E4 diaphragm muscles are analyzed at 0, 12, and 24 h after transdermal Tulobuterol treatment. The force-frequency curves of E0 and E4 diaphragm muscles at three time points are not significantly changed each other, indicating that Tulobuterol patch restores the muscle contractility. Thus, diaphragm muscle contractility is maintained during 4 h of endotoxin administration with Tulobuterol patch for over 24 h[3].
Tulobuterol hydrochlorideSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- +86 (0) 571 85 58 67 18
- Tel
- 13817811078
- sales@jingyan-chemical.com
- Tel
- 001-857-928-2050 or 1-888-588-9418
- sales@chemreagents.com
- Tel
- 021-50135380
- shchemsky@sina.com
Tulobuterol hydrochloride(56776-01-3)Related Product Information
- 1-AdaMantanethylaMine
- tert-Butyldimethylsilyl chloride
- Tulobuterol
- Aminoacetonitrile hydrochloride
- D-Glucosamine hydrochloride
- Methylparaben
- Diphenhydramine Hydrochloride
- N,N-Dimethyl-1,4-phenylenediamine
- Topotecan hydrochloride
- Bensulfuron methyl
- tert-Butyl methyl ether
- Kresoxim-methyl
- 2-Methyl-1-phenyl-2-propanol
- Ciprofloxacin hydrochloride
- Methyl acrylate
- Thiophanate-methyl
- 4-TERT-BUTYLBENZYL ALCOHOL
- Tris(hydroxymethyl)aminomethane